Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
265
-
Total 13F shares, excl. options
-
51.7M
-
Shares change
-
-101K
-
Total reported value, excl. options
-
$1.72B
-
Value change
-
-$19.9M
-
Put/Call ratio
-
1.52
-
Number of buys
-
128
-
Number of sells
-
-134
-
Price
-
$33.22
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2018
324 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2018.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.7M shares
of 56M outstanding shares and own 92.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.08M shares), Vanguard Group Inc (5.24M shares), FMR LLC (2.08M shares), STATE STREET CORP (1.7M shares), Champlain Investment Partners, LLC (1.57M shares), DIMENSIONAL FUND ADVISORS LP (1.31M shares), Bank of New York Mellon Corp (1.21M shares), GLENMEDE TRUST CO NA (1.2M shares), Fiera Capital Corp (942K shares), and Invesco Ltd. (929K shares).
This table shows the top 265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.